Yes, the fight against these forces is difficult because

New Post Public Reply Private Reply Replies (5) Message Board
MGK_2
908
Yes, the fight against these forces is difficult because they have been there for a long time. They have become entrenched and they enjoy their habitation and don't want to give it up.
We are all about revolution, against all that tyranny. It is not all about them. It is not all about how they can make more with expensive bandaids. No. Now, the tide has turned. It is about Normalization. It is about proper operation. It is about self cure.
How do we propose the return back to baseline? The normal ratio, the normal balance, how are these achieved? Add Leronlimab. It all comes back to this new found mechanism of action that was discovered in the long haulers trial, where CCR5 numbers increased in patients who responded to LL when they had been decreased resulting from long bouts of covid sickness.
Remember the Tower of Babel. All the peoples of the Earth lived together and were growing in knowledge and power. They all spoke one language and took stones and made mortar and built a tower and then they were growing in power. God looked down and did not appreciate their growing might and wanted to put a stop to that. What did He do? He confounded their languages. Nobody spoke the same language anymore. Nobody could understand what the other was saying. That put an end to the tower and people found others who spoke like they did and went to different parts of the Earth to reside. God does not like "one ness". He likes to separate groups. He like the fact that there are multiple countries on Earth. He likes borders between them.
This sharing, or one world order, or one world religion is not in line with how He operates. Anyway, back to the analogy. How does Leronlimab play God? Well, nothing can bind to CCR5 better than LL. Not HIV, not even CCL5. Remember that CCR5 is a cytokine doing the communication at the heart of the Immunomodulatory Cascade of events which produce appropriate inflammatory response for a given stimulus of disease. Well, when everything is operating as it should, and everything is in balance and the ratios are correct, CCR5 is communicating with a bunch of other cytokines getting things done appropriately. Bacteria, virus', fungi, etc are getting killed. New found diseases are discovered and fought against. Memory is formed and maintained so when it is encountered again, the antibodies may quickly be manufactured. Those antibodies are helped to be manufactured. It's a conglomerate of an Army, working with a Navy, which works with an Air Force, a Space Force, who all work with Marines and Coast Guard. Everyone has their own special function and everyone does it well because CCR5 is in good quantity and free and available to communicate.
Now disease comes forth and spews CCL5 into the heart of the communication pathway of the immune system. Cancer, tumors exude CCL5 cytokine which strongly binds to CCR5 effectively jamming communication between all the militia. Available and free surface expression CCR5 dwindles. No communication and the militia begins working for the enemy, building a vascular blood supply for the tumors, deluding the T-regulatory cells to trick the natural killer cytotoxic T cells not to kill the tumor cells and to leave them alone and to allow them to freely pass through the arteries and veins to become circulating tumor cells and metastasize.
No, the object of the game is not to build a massive Tumor, nor is it to proliferate a cancer. The object is to keep a human being free from cancer. Free from fatty liver. Free from scarred liver.
When CCR5 communication is used in excess or the opposite, if there is a lack of use of CCR5, something is wrong. If it is used in excess, it has been hijacked in the way CCL5 Rantes jammed up the Internet/Interleukin signal. If there is a lack in communication, cells are so fatigued, they are unable to produce more CCR5.
People were not supposed to be talking the same language. There had to be various modes of thought and to allow that, God had to break it up. Someone was leading those people to build this gawky tower. Why the hell was it necessary? Because someone at the top had an idea and they had to comply. That was shut down. Leronlimab is added, it takes out the CCL5, and LL goes in its place. The difference is though, that LL does not shut down the communication for Adaptive Immunity. It allows CCR5 to continue to work and communicate for Adaptive Immunity. It does however shut down the communication for Innate Immunity, (built in which is more inflammatory). So, LL blocks off the jammer and there is nothing which binds to CCR5 with more affinity than LL and it has a half month of about a month.
Can you see now that LL has fixed the problem at its source. It confounds the enemy. It normalizes human immuno-physiology allowing our own immune systems to address every pathology it normally would provided its cellular communication channels, the internet/interleukin between the various flanks of militia remain robust and operational, free of jammed communication or black out periods. Even when there is a dearth of communication, Leronlimab induces the restoration and normalization of appropriate communication levels for the purpose of keeping the human body free and clear of disease. Leronlimab is harmless if given to a healthy individual and does not affect their capacity to fight disease. When given to a patient who has developed a disease caused by a faulty immune system, it restores proper communication between the troops so they may form the appropriate means to eradicate the foe. Anytime inflammation exists in the body, it is the job of the immune system to eradicate that.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

GoDaddy Faces Class Action: Investor Stakes High

Updated Category News Views 3

GoDaddy's Legal Turbulence: What's at Stake? Sometimes riding the stock wave can hit unexpected snags, and that's what's up with GoDaddy right now. They're stuck in the middle of a securities deception storm that's sending shivers down the spine of many an investor. The Class Action Lawsuit's Core Here's what you need to know: GoDaddy, with its ticker NYSE:GDDY, is...

Continue Reading
Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Updated Category News Views 0

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Continue Reading
Dreame Unveils Vast AI Product Range at IFA 2026

Updated Category News Views 0

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Continue Reading
Pudu Robotics Showcases Expansive Portfolio at IFA 2026

Updated Category News Views 2

Robotics in the Spotlight: Pudu's Grand European Entry Well, you don't see this every day—Pudu Robotics, a name riding high in the robotics sphere, is strutting its stuff over at IFA 2026 in Berlin. This ain't just a teaser, folks. They're unloading the whole toolkit, diving head-first into the European market. From gears turning in service delivery bots to industrial...

Continue Reading
PrimeBOT Shines at IFA 2026 with Innovative Awards

Updated Category News Views 5

A New Chapter in Home Robotics In today's tech-centric world, newcomers often confuse flash with substance. But every now and then, you catch a glimpse of something that might just change how the world spins. At this year's IFA 2026, PrimeBOT didn't just dip its toes into the limelight—it cannonballed right in, drumming up some serious buzz with its PrimeBOT T1 and...

Continue Reading
Labcorp Faces Lawsuit: Wiretapping Accusations Surface

Updated Category News Views 3

Labcorp's Legal Tangle Unveiled One minute you're on Labcorp's website searching for medical info, the next you're caught up in a class-action legal whirlwind. Legal drama is not on any patient’s checklist, but here we are, with Labcorp knee-deep in some serious allegations. The crux of the matter points to alleged wiretapping violations, with claims that Labcorp,...

Continue Reading
Shenzhen Media Push: Shaping Asia-Pacific's Future

Updated Category News Views 0

A Metamorphosis in Shenzhen You ever hear about a place that rockets from obscurity to global significance in the blink of an eye? Well, Shenzhen, China is that place. Forty years ago, it was just a quaint fishing village. Fast forward a few decades, and you've got yourself an international powerhouse—a testament to China's rapid development strategy. Shenzhen is now...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 5

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 2

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
TECNO's Modular Phone and Mini-PC Win Big at IFA 2026

Updated Category News Views 0

The Tale of Two Game-Changers TECNO has just scooped up two big-time awards, and I'm here to break it down like no glossy magazine ever could. Picture this: a brand that knows how to keep its foot on the innovation pedal and doesn't shy away from shaking up the tech world. TECNO's got the goods, claiming two prestigious IFA Global Product Technology Innovation Awards this...

Continue Reading

Top 5 Most Recently Viewed Articles

Ferrari Set to Share Q3 2025 Financial Insights Soon

Updated Category News Views 326

Ferrari Prepares for Upcoming Q3 2025 Financial Release Ferrari N.V., a brand synonymous with luxury and high-performance sports cars, is gearing up to release its financial results for the third quarter of 2025. This eagerly awaited announcement is scheduled for a Tuesday release, specifically on November 4, 2025. What to Expect from the Financial Results The forthcoming...

Continue Reading
Insights into Reddit's Recent Stock Performance and Investor Concerns

Updated Category News Views 196

Understanding Reddit's Stock Fluctuations Reddit, Inc. has attracted significant attention lately due to some troubling developments affecting its stock, particularly involving the ticker RDDT. Concerns about the company's performance have prompted investigations into possible mismanagement and investor losses. Investors who may feel impacted are strongly encouraged to...

Continue Reading
CSX Reports Q4 Earnings: Key Insights for Investors

Updated Category News Views 114

CSX Q4 Earnings Overview CSX has recently disclosed its earnings for the fourth quarter. During this announcement, the company reported mixed results, presenting figures that raised some eyebrows in the financial community. Understanding these insights is crucial for investors looking to navigate their portfolio amid these updates. Earnings Performance Breakdown Current...

Continue Reading
Exciting New Townhome Community Launched by Toll Brothers

Updated Category News Views 160

Introducing the Rivercrest Townhome Community Excitement is building as Toll Brothers, the renowned luxury homebuilder, prepares to introduce the Rivercrest Townhome Community, set to open soon. This exclusive collection of townhomes brings an exceptional living opportunity to homeowners who desire both comfort and convenience. Located within a vibrant area, this...

Continue Reading
Transforming a $100 Investment Today: Carrier Global Insights

Updated Category News Views 124

How A $100 Investment In Carrier Global Can Impact Your Future Investing can be a daunting journey, but it can also be incredibly rewarding. If you had invested $100 in Carrier Global (CARR) five years ago, your investment would have significantly appreciated over time. Understanding the dynamics of this company can inspire current and potential investors alike....

Continue Reading